Amid the continued deluge of emergency use authorizations from the FDA, rapid antigen tests for COVID-19 are more widely available and easily accessible than ever. Source: FierceBiotech

In a study that compares rapid antigen and laboratory PCR approaches for COVID-19 serial screening, researchers affiliated with the NIH RADx initiative reported results from 43 people infected with the virus.

NIH researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases. For every diagnosed COVID-19 case in this time frame, the researchers estimate that there were 4.8 undiagnosed cases, representing an additional 16.8 million cases by July alone.

A change of instructions in a computer program directs the computer to execute a different command. Similarly, synthetic biologists are learning the rules for how to direct the activities of human cells.

This study investigates how the nucleocapsid protein, or N protein, of the SARS-CoV-2 virus packages the viral genome.

Unlike many other viral testing platforms, MatMaCorp’s all-in-one Solas 8 testing device provides results for six samples in 120 minutes and doesn’t require the additional lab support often lacking in rural areas. To help make the pivot to the human health market, the company applied to the NIH RADx initiative, Source: VentureWell

A team of NIH microscopists and computer scientists used a type of artificial intelligence called a neural network to obtain clearer pictures of cells at work even with extremely low, cell-friendly light levels.

Thinking back to a year ago when terror struck worldwide and the full weight of the Covid-19 pandemic began to set in, NIH quickly mobilized on multiple fronts—one of which was the RADx initiative, with the goal of helping to meet the huge demand for fast, accurate Covid-19 tests. Source: NIH Record.

NIBIB-funded researchers are investigating long-lasting, customizable nanobubbles for ultrasound contrast agents.